Skip to content
Home » Crafilm

Crafilm

    Crafilm

    Crafilm (APR’S Specifications, Sucralfate USP, Calcium carbonate BP) tablet is composed of Sucralfate which belongs to a group of medicines known as protectants.

    It shows effectiveness by sticking to damaged ulcers and tissues and protecting against enzymes and acids so that healing can occur.

    Uses: This medicine is used for the treatment of EPIGASTRIC DISTRESS SYNDROME. It is used for the prevention and treatment of ulcers in the intestines.

    Crafilm

    Package Contains:

    It contains 32 chewable tablets.

    Composition:

    Each chewable tablet contains:

    Sucralfate USP 250mg

    Calcium carbonate BP 100mg

    APR’S Specifications.

    Dosage:

    As directed by the physician. Product should be administered before each meal and at bedtime.

    Adults: 1-2 tablets.

    Crafilm back

    Children: 6-12 years: 1/2 – 1 tablet.

    1-6 years: 1/4 – 1/2 tablet.

    Indications:

    Epigastric Distress Syndrome (EDS) includes different upper abdominal complaints, Non-ulcer dyspepsia, Flatulent, Essential dyspepsia, Gastritis.

    Contraindications:

    There are no contraindications to the use of Crafilm Chewable Tablets. However, use in pregnancy or lactation with caution.

    Precautions:

    Please consult your doctor if you are pregnant or breastfeeding.

    Side effects:

    The only side effect found in the patients is constipation.

    Cautions:

    Protect from direct sunlight. Store below 30ᵒC. Keep out of reach of children. Use as directed by the physician.

    Links:

    Manufactured by: PACIFIC Pharmaceuticals Ltd. Pakistan’s first MHRA Certified ^(https://medicineslist.com/goto/https://pacificpharmaceuticals.com/)

    You can buy online from: Crafilm Tablet 250mg ^(https://medicineslist.com/goto/https://nexthealth.pk/product/crafilm-tablet-250mg-100mg-32s-16859/?drug_form=Suspension)

     

    By: Muhammad Usama Iftikhar

    Leave a Reply

    Your email address will not be published. Required fields are marked *